Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Interim Management Statement

8 Aug 2012 07:00

RNS Number : 5235J
Avon Rubber PLC
08 August 2012
 



Strictly embargoed until 07:00 Wednesday 8 August 2012

AVON RUBBER p.l.c. ("Avon", the "Group" or the "Company")

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD FROM 1 APRIL 2012 TO 7 AUGUST 2012

Protection & Defence

In Protection & Defencethe full yearorder intake for the Division is expected to be 38% up on the previous year and with a significant element of this for delivery in future years, we have improved visibility of revenues from both the DoD and commercial customers for 2013.

 

Orders in hand from the US Department of Defense (DoD) will allow us to deliver similar volumes of the M50 respirator in the second half of our 2012 financial year to the first half of the year. As expected we have seen an acceleration in the delivery of spare filters to the DoD since the half year, albeit the overall level of filter orders will be below that of the previous year. We expect filter demand to grow as more mask systems are delivered although customer scheduling of filter deliveries remains difficult to predict.

 

Project Fusion, our new program to expand and enhance our product range, remains on track to provide further organic growth from 2013/4.

 

Dairy

In Dairy we have seen further growth in sales of our Milk-Rite brand, in particular the Impulse Mouthpiece Vented Liner. Our sales and distribution centre in China is progressing well, in line with expectations.

 

Net debt

The Group's balance sheet remains robust. Net debt at 30 June 2012 was £10.2m (30 September 2011: £11.8m) reflecting the timing of working capital movements and the significant investment made in product development during the year. 

 

Outlook

The business as a whole has progressed further in this period with continued investment in product development and our brands and distribution channels. With improved operational performance from Protection & Defence and the Dairy business performing strongly, we continue to expect that the results for the second half of the year will be stronger than the first half with year on year growth comparable with the level seen during the first half.

For further enquiries, please contact:

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896870

Sarah Matthews-DeMers, Group Financial Controller

01225 896835

Miles Ingrey-Counter, Company Secretary

01225 896850

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

 

 

 

 

  

 

 

 

 

NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological,Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder,

emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced

CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised

solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and

tubing for the automated milking process. For further information please visit the Group's website www.avon‐rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSAFMWFESEDA
Date   Source Headline
18th Dec 201710:18 amRNSNotice of Annual Report and Accounts and AGM
6th Dec 20173:39 pmRNSDirector/PDMR Shareholding
6th Dec 20172:14 pmRNSDirector/PDMR Shareholding
6th Dec 20177:00 amRNSUS Department of Defense Mask Systems Order
30th Nov 20174:20 pmRNSDirector/PDMR Shareholding
29th Nov 201711:10 amRNSDirector/PDMR Shareholding
24th Nov 20174:39 pmRNSDirector/PDMR Shareholding
15th Nov 20177:00 amRNSFinal Results
8th Nov 20177:00 amRNSAward of US JE-RDAP CBRNe framework contract
7th Nov 201712:15 pmRNSDirector/PDMR Shareholding
3rd Nov 201712:30 pmRNSPreferred bidder nomination
6th Oct 20173:42 pmRNSDirector/PDMR Shareholding
20th Sep 20175:01 pmRNSHolding(s) in Company
15th Sep 20177:00 amRNSPre-close trading update
12th Sep 20179:13 amRNSDirector/PDMR Shareholding
8th Sep 20179:07 amRNSDirector/PDMR Shareholding
4th Sep 201711:06 amRNSHolding(s) in Company
31st Aug 20174:08 pmRNSDirector/PDMR Shareholding
21st Aug 20172:06 pmRNSHolding(s) in Company
21st Aug 20171:53 pmRNSHolding(s) in Company
17th Aug 20177:00 amRNSAppointment of Corporate Broker
14th Aug 20179:59 amRNSDirector/PDMR Shareholding
9th Aug 201710:16 amRNSDirector/PDMR Shareholding
8th Aug 20173:33 pmRNSDirector/PDMR Shareholding
8th Aug 20171:23 pmRNSHolding(s) in Company
31st Jul 201711:03 amRNSDirector/PDMR Shareholding
6th Jul 20171:18 pmRNSDirectors'/PDMR Shareholdings - SIP
6th Jun 201711:51 amRNSDirector/PDMR Shareholding
23rd May 20177:00 amRNSContract Award
16th May 20177:00 amRNSHalf-year Report
10th May 20177:00 amRNSDirectorate Change
8th May 201712:31 pmRNSDirector/PDMR Shareholding
6th Apr 20174:03 pmRNSDirector/PDMR Shareholding
7th Mar 201710:34 amRNSDirector/PDMR Shareholding
17th Feb 20175:45 pmRNSHolding(s) in Company
15th Feb 20172:34 pmRNSDirector/PDMR Shareholding
15th Feb 20177:00 amRNSDirectorate Change
8th Feb 20174:11 pmRNSDirector/PDMR Shareholding
3rd Feb 20175:22 pmRNSHolding(s) in Company
2nd Feb 20175:13 pmRNSResult of AGM
2nd Feb 20177:00 amRNSTrading Update
26th Jan 20179:37 amRNSHolding(s) in Company
9th Jan 201710:20 amRNSDirector/PDMR Shareholding
3rd Jan 201710:14 amRNSHolding(s) in Company
20th Dec 20168:52 amRNSHolding(s) in Company
9th Dec 201610:43 amRNSDirector/PDMR Shareholding
9th Dec 201610:42 amRNSAnnual Report and Financial Statements 2015
7th Dec 20164:07 pmRNSDirector/PDMR Shareholding
5th Dec 20163:24 pmRNSDirector/PDMR Shareholding
1st Dec 201612:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.